Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps—Single-Center Experience over More Than a Decade

The management of chronic thromboembolic pulmonary hypertension has significantly changed over the last decade with the availability of both specific therapies and interventional treatments. In parallel, implantable pumps for intravenous administration of treprostinil have broadened the spectrum of...

書誌詳細
主要な著者:	Regina Steringer-Mascherbauer, Charlotte Huber, Uwe Fröschl, Dagmar Engleder, Reinhold Függer, Maria Lummersdorfer, Ralf Lenhard, Martin Martinek
フォーマット:	論文
言語:	English
出版事項:	MDPI AG 2023-07-01
シリーズ:	Journal of Cardiovascular Development and Disease
主題:	chronic thromboembolic pulmonary hypertension implantable pump intravenous treprostinil
オンライン･アクセス:	https://www.mdpi.com/2308-3425/10/8/318

類似資料

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil
著者:: Pavel Jansa, 等
出版事項: (2023-07-01)

Long-term experience with implantable infusion pumps for intravenous treprostinil in pulmonary arterial hypertension—procedural safety and system-related complications
著者:: Regina Steringer-Mascherbauer, 等
出版事項: (2020-11-01)

Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension
著者:: John W. Swisher, PhD, MD, 等
出版事項: (2017-01-01)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
著者:: Jan C. Kamp, 等
出版事項: (2021-05-01)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
著者:: Marcin Kurzyna, 等
出版事項: (2017-12-01)

Venoarterial extracorporeal membrane oxygenation for vasoplegic shock after treprostinil refill of an implanted intravenous pump: a case report
著者:: Lucía Valencia, 等
出版事項: (2024-01-01)

The effects of standardized intravenous treprostinil in pulmonary arterial hypertension patients after total cavo-pulmonary connection procedure
著者:: Xiaofeng Wang, 等
出版事項: (2024-10-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
著者:: Julia McSweeney, 等
出版事項: (2023-04-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
著者:: Lianghua Xiao, 等
出版事項: (2024-09-01)

Design, Development, and Evaluation of Treprostinil Embedded Adhesive Transdermal Patch
著者:: Ibrahim Alissa, 等
出版事項: (2023-04-01)

Prenatal treprostinil reduces the pulmonary hypertension phenotype in the rat model of congenital diaphragmatic hernia
著者:: Felix Rafael De Bie, 等
出版事項: (2022-07-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
著者:: Piotr Kędzierski, 等
出版事項: (2025-01-01)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
著者:: Enhuan Wei, 等
出版事項: (2023-11-01)

Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
著者:: Daniel Lachant, DO, 等
出版事項: (2025-05-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
著者:: Nicholas S. Hill, 等
出版事項: (2022-07-01)

Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function
著者:: Aleksandra Judina, 等
出版事項: (2023-12-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
著者:: Aparna C. Swaminathan, 等
出版事項: (2024-11-01)

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
著者:: Leslie A. Spikes, 等
出版事項: (2022-04-01)

Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder
著者:: Helena Gauani, 等
出版事項: (2022-04-01)

Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report
著者:: Jacqueline Brewer, 等
出版事項: (2023-06-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
著者:: Shelsey W. Johnson, 等
出版事項: (2022-07-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
著者:: Garance Kopp, 等
出版事項: (2020-10-01)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
著者:: Helena Gauani, 等
出版事項: (2023-03-01)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
著者:: Donna Steinbacher, 等
出版事項: (2024-04-01)

Renal infarction associated with low dose intravenous immunoglobulin in a kidney transplant recipient with sepsis: a case report and literature review
著者:: Eun Woo Choi, 等
出版事項: (2021-10-01)

Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients
著者:: N. V. Marukyan, 等
出版事項: (2021-05-01)

Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
著者:: N M Danilov, 等
出版事項: (2019-04-01)

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review
著者:: Burger CD, 等
出版事項: (2024-05-01)

Direct prostacyclin transition in pediatric patients with pulmonary hypertension
著者:: Kelly Merrill, 等
出版事項: (2024-04-01)

Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
著者:: Cheng Hong, 等
出版事項: (2022-05-01)

Efficacy and safety of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
著者:: Zheng-Wei Chen, 等
出版事項: (2021-03-01)

Cation exchange chromatography removes FXIa from a 10% intravenous immunoglobulin preparation
著者:: Gil Bu Kang, 等
出版事項: (2023-11-01)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
著者:: Diederik P. Staal, 等
出版事項: (2024-07-01)

Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension
著者:: Chen TX, 等
出版事項: (2018-01-01)

Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty
著者:: Qi Jin, 等
出版事項: (2019-11-01)

Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease
著者:: HUANG Shenshen, 等
出版事項: (2023-01-01)

Congruency between clinician‐assessed risk and calculated risk of 1‐year mortality in patients with pulmonary arterial hypertension: A retrospective chart review
著者:: Amresh Raina, 等
出版事項: (2024-10-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
著者:: Jenna M. Faircloth, 等
出版事項: (2023-08-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
著者:: Jenna M. Faircloth, 等
出版事項: (2023-03-01)

Perioperative thromboembolism prophylaxis in children – is it necessary?
著者:: Izabela Pągowska-Klimek
出版事項: (2020-08-01)